The 10-week study of the drug dronabinol, which contains tetrahydrocannabinol or THC directly from the cannabis plant, is believed to be the first of its kind to study the drug’s impact on PTSD-related nightmares.
THC drug eliminated nightmares for over a third of PTSD patients in German trial
Recent Comments